Effect of glutamate carboxypeptidase II and reduced folate carrier polymorphisms on folate and total homocysteine concentrations in dialysis patients

Journal of the American Society of Nephrology

Volumn 14, Issue 5, 2003, Pages 1314-1319

  Födinger, Manuela ^a   Dierkes, Jutta ^b   Skoupy, Sonja ^a   Röhrer, Claudia ^a   Hagen, Wolfgang ^a   Puttinger, Heidi ^a   Hauser, Anna Christine ^a   Vychytil, Andreas ^a   Sunder Plassmann, Gere ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CREATININE; FOLIC ACID; GAMMA GLUTAMYL HYDROLASE; GLUTAMATE CARBOXYPEPTIDASE II; HOMOCYSTEINE; REDUCED FOLATE CARRIER; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; AMINO ACID BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; CGP2 GENE; CREATININE BLOOD LEVEL; DIALYSIS; ERYTHROCYTE LEVEL; FEMALE; FOLIC ACID BLOOD LEVEL; GENE; GENOTYPE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0345373993     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000064949.67401.D3     Document Type: Article

References (31)

1. Dierkes J, Jeckel A, Ambrosch A, Westphal S, Luley C, Boeing H: Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam Study. Metabolism 50: 640-645, 2001
2. Födinger M, Mannhalter C, Wölfl G, Pabinger I, Müller E, Schmid R, Hörl WH, Sunder-Plassmann G: Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Kidney Int 52: 517-523, 1997
3. Födinger M, Wölfl G, Fischer G, Rasoul-Rockenschaub S, Schmid R, Hörl WH, Sunder-Plassmann G: Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients. Kidney Int 55: 1072-1080, 1999
4. Vychytil A, Födinger M, Wölfl G, Enzenberger B, Auinger M, Prischl F, Buxbaum M, Wiesholzer M, Mannhalter C, Hörl WH, Sunder-Plassmann G: Major determinants of hyperhomocysteinemia in peritoneal dialysis patients. Kidney Int 53: 1775-1782, 1998
5. 12 plasma concentrations in kidney graft recipients. J Am Soc Nephrol 11: 1918-1925, 2000
6. Skoupy S, Födinger M, Veitl M, Perschl A, Puttinger H, Röhrer C, Schindler K, Vychytil A, Hörl WH, Sunder-Plassmann G: Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients. J Am Soc Nephrol 13: 1331-1337, 2002
7. Dierkes J, Domröse U, Ambrosch A, Bosselmann HP, Neumann KH, Luley C: Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease. Clin Nephrol 51: 108-115, 1999
8. Sunder-Plassmann G, Födinger M, Gohh RY, Selhub J, Bostom AG: Cyclosporine use is not independently associated with increased plasma thcy levels in Austrian or United States chronic renal transplant recipients. J Am Soc Nephrol 11: 726A, 2000
9. Hauser AC, Hagen W, Rehak PH, Buchmayer H, Födinger M, Papagiannopoulos M, Bieglmayer C, Apsner R, Köller E, Ignatescu M, Hörl WH, Sunder-Plassmann G: Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients. Am J Kidney Dis 37: 758-765, 2001
10. Födinger M, Buchmayer H, Heinz G, Papagiannopoulos M, Kletzmayr J, Perschl A, Vychytil A, Hörl WH, Sunder-Plassmann G: Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients. Am J Kidney Dis 38: 77-84, 2001
11. Feix A, Fritsche-Polanz R, Kletzmayr J, Vychytil A, Hörl WH, Sunder-Plassmann G, Födinger M: Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels. Am J Kidney Dis 38: 965-964, 2001
12. Devlin AM, Ling E, Peerson JM, Fernando S, Clarke R, Smith AD, Halsted CH: Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet 9: 2837-2844, 2000
13. Chango A, Emery-Fillon N, Portier de Courcy G, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP: A polymorphism (80G>A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 70: 310-315, 2000
14. Dierkes J, Domröse U, Bosselmann KP, Neumann KH, Luley C: Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease. J Ren Nutr 11: 67-72, 2001
15. American Society of Human Genetics/American College of Medical Genetics Test and Technology Transfer Committee Working Group. ASHG/ACMG statement. Measurement and use of total plasma homocysteine. Am J Hum Genet 63: 1541-1543, 1998
16. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase [letter]. Nat Genet 10: 111-113, 1995
17. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64: 169-172, 1998
18. O'Keefe DS, Su SL, Bacich DJ, Horiguchi Y, Luo Y, Powell CT, Zandvliet D, Russell PJ, Molloy PL, Nowak NJ, Shows TB, Mullins C, Vonder Haar RA, Fair WR, Heston WDW: Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. Biochim Biophys Acta 1443: 113-127, 1998
19. Israeli RS, Powell CT, Fair WR, Heston WDW: Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53: 227-230, 1993
20. Halsted CH: Intestinal absorption of dietary folates. In: Folic Acid Metabolism in Health and Disease, edited by Picciano MF, Stoksatd ELR, Gregory JF, New York, Wiley-Liss, 1990, pp 23-45
21. Yang-Feng TL, Ma YY, Liang R, Prasad PD, Leibach FH, Ganapathy V: Assignment of the human folate transporter gene to chromosome 21q22.3 by somatic cell hybrid analysis and in situ hybridization. Biochem Biophys Res Commun 210: 874-879, 1995
22. Antony AC: The biological chemistry of folate receptors. Blood 79: 2807-2820, 1992
23. Chiao JH, Roy K, Tolner B, Yang CH, Sirotnak FM: RFC-1 gene expression regulates folate absorption in mouse small intestine. J Biol Chem 272: 11165-11170, 1997
24. Lievers K, Kluijtmans L, Boers G, Verhoef P, den Heijer M, Trijbels F, Blom H: Influence of a glutamate carboxypeptidase II 11 (GCPII) polymorphism (1561C->T) on plasma homocysteine, folate and vitamin B(12) levels and its relationship to cardiovascular disease risk. Atherosclerosis 164: 269-273, 2002
25. Vargas-Martinez C, Ordovas JM, Wilson PW, Selhub J: The glutamate carboxypeptidase gene II (C>T) polymorphism does not affect folate status in the Framingham Offspring Cohort. J Nutr 132: 1176-1179, 2002
26. Ghandour H, Bagley PJ, Shemin D, Hsu N, Jacques PF, Dworkin L, Bostom AG, Selhub J: Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid. Kidney Int 62: 2246-2249, 2002
27. van Guldener C, Kulik W, Berger R, Dijkstra DA, Jakobs C, Reijngoud DJ, Donker AJM, Stehouwer CDA, De Meer K: Homocysteine and methionine metabolism in ESRD: A stable isotope study. Kidney Int 56: 1064-1071, 1999
28. Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH: Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 108: 1-6, 2002
29. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Cama A, Finnell RH, Andreussi L, Capra V: Polymorphisms in genes involved in folate metabolism as risk factors for NTDs. Eur J Pediatr Surg 11 Suppl 1: S14-17, 2001
30. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. A meta-analysis. JAMA 288: 2015-2022, 2002
31. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG: MTHFR 677C>T polymorphism and risk of coronary heart disease. A meta-analysis. JAMA 288: 2023-2031, 2002